share_log

Investors Shouldn't Overlook The Favourable Returns On Capital At CDW (NASDAQ:CDW)

Investors Shouldn't Overlook The Favourable Returns On Capital At CDW (NASDAQ:CDW)

投資者不應忽略CDW (納斯達克:cdw) 資本回報率的優勢收益
Simply Wall St ·  06/06 03:02

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. So, when we ran our eye over CDW's (NASDAQ:CDW) trend of ROCE, we really liked what we saw.

要識別一個可以在長期內加倍價值的股票,需要關注哪些早期趨勢?在完美的世界裏,我們希望看到一家公司投資更多資本,並且理想情況下從該資本獲得的回報也在增加。最終,這表明這是一種以遞增的回報率再投資利潤的商業行爲。當我們審視納斯達克股市上CDW公司ROCE的趨勢時,我們看到了讓人欣喜的跡象。

Return On Capital Employed (ROCE): What Is It?

資本僱用回報率(ROCE)是什麼?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. Analysts use this formula to calculate it for CDW:

爲了澄清一下,如果您不確定,ROCE是一種評估公司在其業務中投資的資本中獲得多少稅前收入(以百分比計算)的指標。分析師使用這個公式來爲CDW公司計算:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

資本僱用回報率=利息和稅前收益(EBIT)÷(總資產-流動負債)

0.22 = US$1.7b ÷ (US$13b - US$5.3b) (Based on the trailing twelve months to March 2024).

0.22 = 17億美元 ÷ (130億美元 - 53億美元)在Elevance Health上,我們已經注意到的趨勢是相當令人放心的。數據顯示,過去五年資產回報率大幅提高至15%。投資所用資產的規模也增加了30%。這表明有很多機會進行內部資本投資,並以更高的速度不斷增長,這種組合在多倍增長方面很常見。.

Therefore, CDW has an ROCE of 22%. That's a fantastic return and not only that, it outpaces the average of 11% earned by companies in a similar industry.

因此,CDW的ROCE爲22%。這是一個很棒的回報,而且不僅如此,它還超過了同行業公司所獲得的平均回報率11%。

roce
NasdaqGS:CDW Return on Capital Employed June 5th 2024
納斯達克GS:CDW Return on Capital Employed June 5th 2024

Above you can see how the current ROCE for CDW compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for CDW .

上面您可以看到CDW目前的ROCE與其過去的資本回報率相比,但過去的信息能提供的信息有限。如果您想了解分析師對該公司未來的預測,應查看我們免費的CDW分析師報告。

What The Trend Of ROCE Can Tell Us

資本僱用回報率的趨勢可以告訴我們什麼呢?在Enphase Energy,已經有比我們當前看到的更好的資本收益率了。在過去的五年中,這個公司增加了1306%的資本,而資本回報率在穩定地保持在9.9%這個比較低的水平。這種資本收益率的下降讓人們失去了信心,同時也意味着這個公司沒有將資金投入到高回報的投資中。此外,enphase energy在過去的五年中,已經成功地將流動負債降至總資產的17%,這樣做可以減輕業務的某些風險。

CDW deserves to be commended in regards to it's returns. The company has consistently earned 22% for the last five years, and the capital employed within the business has risen 78% in that time. Now considering ROCE is an attractive 22%, this combination is actually pretty appealing because it means the business can consistently put money to work and generate these high returns. If CDW can keep this up, we'd be very optimistic about its future.

CDW在回報方面值得讚揚。該公司在過去五年中一直保持着22%的回報率,並且企業中使用的資本在此期間增加了78%。現在考慮ROCE爲22%,這種組合實際上非常吸引人,因爲這意味着企業可以持續投入資金併產生高回報。如果CDW能夠保持這種情況,我們對其未來感到非常樂觀。

The Bottom Line

還有一件事需要注意的是,我們已經確定了上海醫藥的2個警告信號,了解這些信號應該成爲你的投資過程的一部分。

In short, we'd argue CDW has the makings of a multi-bagger since its been able to compound its capital at very profitable rates of return. And long term investors would be thrilled with the 122% return they've received over the last five years. So while the positive underlying trends may be accounted for by investors, we still think this stock is worth looking into further.

簡而言之,我們認爲CDW具備成爲多倍收益的潛力,因爲其能夠以非常有利可圖的回報率複合其資本。而長期投資者對過去五年所獲得的122%回報將感到非常高興。因此,儘管積極的潛在趨勢可能已被投資者計入考慮,我們仍認爲這支股票值得進一步探究。

Like most companies, CDW does come with some risks, and we've found 1 warning sign that you should be aware of.

與大多數公司一樣,CDW也存在一些風險,我們發現了1個需要注意的警告信號。

If you want to search for more stocks that have been earning high returns, check out this free list of stocks with solid balance sheets that are also earning high returns on equity.

如果您想尋找更多獲得高回報的股票,請查看這個免費股票列表,這些股票不僅有紮實的資產負債表,而且還有高回報率。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論